Loading...
•
Sep 30, 2021
AdaptHealth Q3 2021 Earnings Report
AdaptHealth achieved record revenue and adjusted EBITDA, driven by organic growth and strategic acquisitions.
Key Takeaways
AdaptHealth reported record revenue of $627.6 million, a 43% increase year-over-year. Adjusted EBITDA was $135.3 million, up 36% year-over-year. The company raised its full-year guidance, reflecting confidence in continued growth.
Net revenue increased to $627.6 million, up 43% year-over-year.
Adjusted EBITDA grew to $135.3 million, a 36% increase year-over-year.
Net income was $13.9 million, compared to a net loss of $7.8 million in the prior year.
The company raised its full-year 2021 net revenue guidance to $2.34 billion to $2.37 billion and adjusted EBITDA guidance to $518 million to $526 million.
Forward Guidance
AdaptHealth raised its full-year 2021 net revenue guidance to $2.34 billion to $2.37 billion and adjusted EBITDA guidance to $518 million to $526 million.
Positive Outlook
- Net revenue guidance increased to $2.34B - $2.37B
- Adjusted EBITDA guidance increased to $518M - $526M
- Expect continued organic growth in core segments.
- Anticipate further benefits from recent acquisitions.
- Strong performance in Q3 2021 provides momentum for the rest of the year.
Challenges Ahead
- Potential for supply chain disruptions to impact product availability.
- Uncertainty regarding the duration and impact of the COVID-19 pandemic.
- Increased competition in the home healthcare market.
- Changes in reimbursement policies could affect profitability.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...